Iodide

Iodide

SCHEMBL5459273

I.Nc1nc(-c2ccc(Oc3ccccc3Cl)cc2)cs1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.68
NPC1 O15118 6/20 0.68
LTA4H P09960 8/20 0.67
ALDH1A1 P00352 8/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
MAPT P10636 4/20 0.54
KDM4E B2RXH2 3/20 0.54
NFKB1 P19838 2/20 0.54
NFKB2 Q00653 2/20 0.54
RELA Q04206 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
AR P10275 1/20 0.50
GFER P55789 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX5 P09917 1/20 0.50
PTGS2 P35354 1/20 0.47
MKNK1 Q9BUB5 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL5459815 0.84 RAB9A (0.97) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
Iodide SCHEMBL5464284 0.84 RAB9A (0.97) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
Iodide SCHEMBL5460208 0.82 RAB9A (0.87) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
Iodide SCHEMBL5456843 0.82 LTA4H (0.97) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
SCHEMBL6256294 0.82 RAB9A (1.00) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
Iodide SCHEMBL5461687 0.80 LTA4H (0.70) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
Iodide SCHEMBL5451467 0.78 LTA4H (0.71) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
Iodide SCHEMBL5460253 0.76 RAB9A (0.71) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
Iodide SCHEMBL5455207 0.76 RAB9A (0.90) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2
SCHEMBL4095582 0.74 LTA4H (0.83) RAB9ANPC1LTA4HALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070082934-A1 Substituted 4-aryloxy and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of cell proliferation UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2007-04-12 US claimed
WO-2005044263-A1 SUBSTITUTED 4-ARYLOXY AND 4-ARYLSULFANYL-PHENYL-2-AMINOTHIAZOLES AS INHIBITORS OF CELL PROLIFERATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2005-05-19 WO claimed
US-20070082934-A1 Substituted 4-aryloxy and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of cell proliferation UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2007-04-12 US disclosed
WO-2005044263-A1 SUBSTITUTED 4-ARYLOXY AND 4-ARYLSULFANYL-PHENYL-2-AMINOTHIAZOLES AS INHIBITORS OF CELL PROLIFERATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2005-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082934-A1 Substituted 4-aryloxy and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of cell proliferation MKI67, CCNI, CDK4 RAB9A 4530/4885NPC1 3129/4885LTA4H 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.